| REGISTERED NUMBER: 08422391 (England and Wales) |
| OSMOSIS (HOLDINGS) LIMITED |
| GROUP STRATEGIC REPORT, |
| REPORT OF THE DIRECTORS AND |
| CONSOLIDATED FINANCIAL STATEMENTS |
| FOR THE YEAR ENDED 31 MARCH 2025 |
| REGISTERED NUMBER: 08422391 (England and Wales) |
| OSMOSIS (HOLDINGS) LIMITED |
| GROUP STRATEGIC REPORT, |
| REPORT OF THE DIRECTORS AND |
| CONSOLIDATED FINANCIAL STATEMENTS |
| FOR THE YEAR ENDED 31 MARCH 2025 |
| OSMOSIS (HOLDINGS) LIMITED (REGISTERED NUMBER: 08422391) |
| CONTENTS OF THE CONSOLIDATED FINANCIAL STATEMENTS |
| FOR THE YEAR ENDED 31 MARCH 2025 |
| Page |
| Company Information | 1 |
| Group Strategic Report | 2 |
| Report of the Directors | 6 |
| Report of the Independent Auditors | 7 |
| Consolidated Income Statement | 10 |
| Consolidated Other Comprehensive Income | 11 |
| Consolidated Balance Sheet | 12 |
| Company Balance Sheet | 13 |
| Consolidated Statement of Changes in Equity | 14 |
| Company Statement of Changes in Equity | 15 |
| Consolidated Cash Flow Statement | 16 |
| Notes to the Consolidated Cash Flow Statement | 17 |
| Notes to the Consolidated Financial Statements | 18 |
| OSMOSIS (HOLDINGS) LIMITED |
| COMPANY INFORMATION |
| FOR THE YEAR ENDED 31 MARCH 2025 |
| DIRECTORS: |
| REGISTERED OFFICE: |
| REGISTERED NUMBER: |
| AUDITORS: |
| 3rd Floor |
| Marlborough House |
| 298 Regents Park Road |
| Finchley |
| London |
| N3 2SZ |
| OSMOSIS (HOLDINGS) LIMITED (REGISTERED NUMBER: 08422391) |
| GROUP STRATEGIC REPORT |
| FOR THE YEAR ENDED 31 MARCH 2025 |
| The directors present their strategic report of the company and the group for the year ended 31 March 2025. |
| REVIEW OF BUSINESS |
| The Osmosis Group has progressed its business satisfactorily during the year. A number of significant initiatives either have been completed or were in progress at the end of the year: |
| (i) Overview |
| The suite of long-only strategies has delivered anticipated performance during a year of unpredictable market conditions. Performance continued to be hindered through the period by an ongoing momentum style based rally, significant concentration of flows into single stock names, particularly technology sector firms, and continued volatility in US trade policy decisions |
| (ii) Australia |
| The Australia Trust, investing in developed markets ex-fossil fuels, saw steady inflow through the period. A private fund investment was successfully secured towards the end of 2024. |
| (iii) North America |
| Two ETFs were launched over the period, in partnership with Harbor Capital. Seeding was secured in size by an institutional investor in North America. The ETs provided our first exposure to Emerging markets and our first unitised offering to our international strategy. |
| (iv) UK |
| Further inroads into the local government pension scheme sector was made in the first half of the year, attracting an allocation of £100m. As pools have been instructed to merge, we see the potential to broaden our footprint in this sector. |
| (v) Diversification |
| The group launched its first strategies in partnership with Harbor Capital, giving our first unitised strategies into North America. Research into multifactor strategies incorporating the Core Resource efficiency signal was started half-way through the year, focussed on strategies oriented to the Asian retail markets. Fund launches are planned for the final quarter of 2025 and the first quarter of 2026. Seeding has been verbally secured to launch Emerging Markets UCITS fund in late 2025. The Group facilitated the launch on a fixed income business based out of the Netherlands. Secured institutional seeding and capital providers and the business successfully launched 2 UCITs funds with significant seed. The group holds an equity stake in the business. |
| (vi) Fixed Income. |
| The Group facilitated the launch of an Osmosis branded Dutch associated company, having secured initial funding for this business and into which a fixed income team have been hired. The first fixed income products were launched midway through 2025 . |
| The Osmosis Group monitors its assets under management and advice ("AuA"), which are the source of the Group's revenue and serve as measures of absolute performance, the changes of which serve to indicate relative performance through time. The AuA levels at the end of the year under review, with the category prior year comparatives follow below. |
| MARKET VOLATILITY AND STRATEGY PERFORMANCE |
| Global equity markets continue to carry risk, though the overall rising trend of equity prices continued during the year. Inflation rates have been showing signs of steadying and, in some areas, falling. Central Banks appear to be becoming more disposed towards reducing base rates to help propel economic growth. The ongoing impact of the Russian war on Ukraine and the increasing polarisation of the US and Chinese attitudes to each other, all keep volatility in markets. |
| In such a market context, the Group's success in gaining new investors, in addition to follow-on flows from existing investors, is a testament to the performance delivered, the depth of the team, and the further strengthening of the Group's operational capabilities. |
| OSMOSIS (HOLDINGS) LIMITED (REGISTERED NUMBER: 08422391) |
| GROUP STRATEGIC REPORT |
| FOR THE YEAR ENDED 31 MARCH 2025 |
| REVIEW OF BUSINESS |
| At the end of the year the Assets under management and advice (AuA) for the Group were: |
| Assets under management and advice | 31 March 2025 | 31 March 2024 |
| Overall AuA | $17,021million | $15,943 million |
| Core Strategies |
| US sub-advised | $286 million | $625 million |
| Core Equity | $6,971 million | $5,666 million |
| Core Equity ex Fossil Fuels | $1,714 million | $1,435 million |
| Core Equity ex Australia | $2,101 million | $1,972 million |
| Core Equity Composite | $5,842 million | $6,103 million |
| Active Strategies |
| ORE European Equities* | $nil | $78 million |
| Emerging Markets |
| Barbor EM ETF | $106 million | $nil |
| Hedge Strategies |
| Market neutral (5 times leverage)* | $nil | $64 million |
| * Fund closed during the year, following investor decisions to re-allocate capital at the end of their planned investment horizon. |
| POSITION OF THE GROUP'S BUSINESS AT THE END OF THE YEAR |
| The Osmosis Group's business position at the end of the financial year was satisfactory. The main features of the group's financial position are as follows: |
| Cash at bank | £0.47 million |
| Shareholders funds | £2.03 million |
| Retained loss for the year | £0.1 million |
| AuA | $17 billion |
| The prospects for the Group are considered to remained good. Investor interest continues to grow in the Group's risk and factor optimised product suite and capabilities. The ability to target better risk adjusted returns while delivering a sustainable benefit, continues to position Osmosis as a unique investment partner. |
| Osmosis continues to broaden its distribution capacity. Intermediary relationships have been created in Japan and Singapore and deepened in Australia and Northern Europe. Those developed in previous years are generating a steady rate of opportunities. The level of prospective investor meetings remained satisfactory during the year with continuing investor interest in Osmosis strategies. |
| OSMOSIS (HOLDINGS) LIMITED (REGISTERED NUMBER: 08422391) |
| GROUP STRATEGIC REPORT |
| FOR THE YEAR ENDED 31 MARCH 2025 |
| PRINCIPAL RISKS AND UNCERTAINTIES |
| The principal risks to the Osmosis Group stem from material sustained abnormalities and shocks to global financial markets, whether these result from negative economic reports, changes in government policy, catastrophe - man-made or natural disaster, or infrastructure failures. Changes in the US and UK governments have had their distinct effects on the investor markets primarily targeted by the firm. The surge in investor interest in technology sector stocks continued to distort equity markets in a way not wholly favourable to resource efficient strategies. Financial markets' volatility and trends may have a significant impact on fund performance and, thence, on the investment decisions taken by allocators. |
| A relatively small number of institutional investors provide a significant portion of the AuA of the Osmosis Group. Re-allocation decisions by one or more of these investors could have a material negative impact on revenues. |
| The Group continues to ensure that all steps are taken to maintain its ability to operate in Europe on an ongoing basis, and it continues to monitor EU requirements' developments closely. |
| Volatility in currency markets, in turn, creates a certain amount of volatility in the sterling value of the Group's income streams, which are partially naturally hedged. As the Group's business builds further, the opportunities to create more stability in those streams are monitored closely. During the year the US dollar generally weakened against sterling, an effect that was offset by the overall uplift in the global developed equity markets. |
| The Osmosis Group's strategy models are quantitative and systematic and, thus, are not subject to manual intervention during normal market conditions. Extreme events are known to occur; however, infrequently, and therefore, the strategy models are subjected periodically to stress tests. |
| The Osmosis Group's principal financial instruments comprise bank balances, trade debtors, trade creditors and convertible loan notes (issued during the year). Bank balances represent the level of liquid resources available to the group in support of normal operations. Trade debtors and creditors arise in the normal course of events; neither are specifically used to provide finance for the Osmosis Group, and significant balances only normally arise due to settlement timing. |
| The objective of the Osmosis Group is to achieve continual above-benchmark growth in the level of investment assets from which its revenues are derived. While the Group is loss-making, the transition into sustained profitability during the next financial year is targeted. Liquidity risk is managed by obtaining sufficient funds from investors and finance providers, in tandem with expenditure control balanced to support ongoing operations, the development of new revenue streams and the enhancement of existing ones. |
| Credit and cash flow risk is managed by monitoring of amounts outstanding for age of debt and against relevant mandates. No credit is extended to customers. Due to the nature of the investors, collection of fees due may take up to 90 days. |
| Trade creditors' liquidity risk is managed by ensuring sufficient funds are available to meet amounts due. |
| Cyber-risks: the level of threat from malicious electronic attack to UK organisations and persons continues to rise. Regulatory focus on this area continues, in particular, by the SEC. The Osmosis Group is not immune to cyber-attacks; it remains alert to the possibility of having its operations significantly compromised by such forms of attack. The directors have accordingly taken all reasonable measures to ensure that the Osmosis Group is both well protected and is able to recover from a breach of defences swiftly. The Group ensures that all of its staff are knowledgeable about all types of extant cyber threats via a programme of ongoing training and awareness testing. It ensures that its infrastructure is as robust as possible and periodically tests its defences. The Group maintains cyber insurance; ongoing investments in infrastructure improvements continue to increase resilience and mitigate foreseeable downside effects. |
| UNCERTAINTIES AND RISKS FOR THE OSMOSIS GROUP |
| Russia's war on Ukraine and the resulting sanctions' imposition continues to impact world markets, as does the US presidential stance on import tariffs, which are reacted to by other major economic players in the world. Price inflation that has been experienced in major economies of the world has been on a downward trend, following Central Banks' interventions. Rising rates, commodity price inflation, new green regulations and societal pressures support the Osmosis investment thesis; however, the prospects for the companies comprising the investable universes for Osmosis strategies are inevitably uncertain, particularly so in the face of both global and regional economic and political economic uncertainties. |
| There will be corporate winners and losers as usual, and market volatility can be expected to increase in the next 12 months. The uncertainty themes of recent years are continuing in 2025 and are expected to continue for the remainder of the decade: the impact of quantitative easing programmes run by many governments over recent years is considered to be declining. Warring in Eastern Europe and the Middle East casts a shadow of uncertainty, although Middle East peace efforts recently could bring some medium term stability. Climate change remains firmly on the agenda, even if other news events shift it from the front page for periods of time. It is recognised that the Group faces uncertainty over income levels, a significant mitigant to which is the focus on meeting investor requirements and attracting allocations of assets to manage. |
| OSMOSIS (HOLDINGS) LIMITED (REGISTERED NUMBER: 08422391) |
| GROUP STRATEGIC REPORT |
| FOR THE YEAR ENDED 31 MARCH 2025 |
| Operationally, the Group continued to operate effectively, with hybrid working as the modus operandi for the foreseeable future. The technology infrastructure flexibility and resilience continue to serve the Group well. |
| VIABILITY OF THE GROUP |
| An element of the Group's risk management approach is to stress-test the business by considering a range of scenarios. Accordingly, around a central case, a number of financial forecast variations are developed, and which are a function of the key factors bearing on income levels, linked variable expense levels and semi-variable expenditure commitments. The development of scenario analysis enables the Group's management to be cognisant of potential sets of conditions to which responses can be planned, which include taking action to reduce expenditure levels and seeking further shareholder support and the speed with which any given action might need to be taken. |
| Included in the range of scenarios considered are those in which a significant and sustained fall in global equity markets is experienced. The Group has the ability to withstand such conditions should they occur and to take all appropriate actions to sustain the continuation of the Group. |
| Within the scope of the forward planning and scenario analysis sits the requirement to ensure that the Group is able to meet the FCA's applicable capital requirements and funding obligations. There is therefore careful and continuous monitoring of the Group's position with respect to both aspects. |
| The Financial Reporting Council requires all companies to rigorously assess all the factors affecting the business when deciding to adopt a going-concern basis for the preparation of accounts. Having reviewed results of stress-tests, as well as the Group's financial plans and level of resources, the Board considers the adoption of the going-concern basis to be appropriate. |
| DIRECTOR' STATEMENT OF COMPLIANCE WITH DUTY TO PROMOTE THE SUCCESS OF THE GROUP |
| The Osmosis Group is an investment manager and research house, focused on sustainability and environment foot-printing. It provides the opportunity to investors to allocate their assets to a range of investment strategies, all of which are centred on quantitative methods of optimizing portfolios based on the efficient use of resources by the universe of investable companies. The effective management of assets allocated by clients is of paramount importance to the Group. |
| The Directors of Osmosis (Holdings) Limited have acted in accordance with their duties codified in law, which include their duty to act in the way in which they consider, in good faith, would be most likely to promote the success of the Company for the benefit of its members as a whole, having regard to the stakeholders and matters set out in section 172(1) of the Companies Act 2006. |
| Section 172 considerations are embedded in the decision making at Board level and throughout the Group. |
| ON BEHALF OF THE BOARD: |
| 29 October 2025 |
| OSMOSIS (HOLDINGS) LIMITED (REGISTERED NUMBER: 08422391) |
| REPORT OF THE DIRECTORS |
| FOR THE YEAR ENDED 31 MARCH 2025 |
| The directors present their report with the financial statements of the company and the group for the year ended 31 March 2025. |
| PRINCIPAL ACTIVITIES |
| During the year the principal activities of the group were a holding company, to provide investment management services and to be involved in the development of intellectual property and provision of services. |
| DIVIDENDS |
| No dividends will be distributed for the year ended 31 March 2025. |
| DIRECTORS |
| The directors shown below have held office during the whole of the period from 1 April 2024 to the date of this report. |
| STATEMENT OF DIRECTORS' RESPONSIBILITIES |
| The directors are responsible for preparing the Group Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations. |
| Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the group and of the profit or loss of the group for that period. In preparing these financial statements, the directors are required to: |
| - | select suitable accounting policies and then apply them consistently; |
| - | make judgements and accounting estimates that are reasonable and prudent; |
| - | prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business. |
| The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's and the group's transactions and disclose with reasonable accuracy at any time the financial position of the company and the group and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and the group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. |
| STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS |
| So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the group's auditors are unaware, and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the group's auditors are aware of that information. |
| AUDITORS |
| The auditors, Duncan & Toplis Audit Limited, Statutory Auditor, will be proposed for re-appointment at the forthcoming Annual General Meeting. |
| ON BEHALF OF THE BOARD: |
| REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF |
| OSMOSIS (HOLDINGS) LIMITED |
| Opinion |
| We have audited the financial statements of Osmosis (Holdings) Limited Group (the 'parent company') and its subsidiaries (the 'Group') for the year ended 31 March 2025 which comprise the Consolidated Income Statement, Consolidated Other Comprehensive Income, Consolidated Balance Sheet, Company Balance Sheet, Consolidated Statement of Changes in Equity, Company Statement of Changes in Equity, Consolidated Cash Flow Statement and Notes to the Consolidated Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice). |
| In our opinion the financial statements: |
| - | give a true and fair view of the state of the group's and of the parent company affairs as at 31 March 2025 and of the group's loss for the year then ended; |
| - | have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and |
| - | have been prepared in accordance with the requirements of the Companies Act 2006. |
| Basis for opinion |
| We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the group in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. |
| Conclusions relating to going concern |
| In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. |
| Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and the parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. |
| Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report. |
| Other information |
| The directors are responsible for the other information. The other information comprises the information in the Group Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon. |
| Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. |
| In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard. |
| Opinions on other matters prescribed by the Companies Act 2006 |
| In our opinion, based on the work undertaken in the course of the audit: |
| - | the information given in the Group Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and |
| - | the Group Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements. |
| REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF |
| OSMOSIS (HOLDINGS) LIMITED |
| Matters on which we are required to report by exception |
| In the light of the knowledge and understanding of the group and the parent company and its environment obtained in the course of the audit, we have not identified material misstatements in the Group Strategic Report or the Report of the Directors. |
| We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion: |
| - | adequate accounting records have not been kept by the parent company, or returns adequate for our audit have not been received from branches not visited by us; or |
| - | the parent company financial statements are not in agreement with the accounting records and returns; or |
| - | certain disclosures of directors' remuneration specified by law are not made; or |
| - | we have not received all the information and explanations we require for our audit. |
| Responsibilities of directors |
| As explained more fully in the Statement of Directors' Responsibilities set out on page six, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. |
| In preparing the financial statements, the directors are responsible for assessing the group's and the parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the group or the parent company or to cease operations, or have no realistic alternative but to do so. |
| Auditors' responsibilities for the audit of the financial statements |
| Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. |
| The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below: |
| - Reviewing the financial statement disclosures and testing to supporting documentation to assess |
| compliance with provisions of relevant laws and regulations described as having a direct effect on the financial statements. |
| - Enquiring of management concerning actual and potential litigation and claims. |
| - Performing analytical procedures to identify any unusual or unexpected relationships that may indicate risks of material misstatement due to fraud. |
| - Reading minutes of meetings of those charged with governance. |
| - In addressing the risk of fraud through management override of controls, testing the appropriateness of journal entries and other adjustments; assessing whether the judgements made in making accounting estimates are indicative of a potential bias; and evaluating the business rationale of any significant transactions that are unusual or outside the normal course of business. |
| We also communicated relevant identified laws and regulations and potential fraud risks to all engagement team members, and remained alert to any indications of fraud or non-compliance with laws and regulations throughout the audit. |
| Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment forgery, collusion, omission or misrepresentation. |
| Whilst this is the case, our audit approach adopts a risk based approach which ensures that appropriate attention is devoted to the areas assessed as key audit risks. We performed a combination of procedures Including analytical review, detailed substantive verification of transactions and balances as well as detailed test of controls, where appropriate. |
| A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors. |
| REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF |
| OSMOSIS (HOLDINGS) LIMITED |
| Use of our report |
| This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed. |
| for and on behalf of |
| 3rd Floor |
| Marlborough House |
| 298 Regents Park Road |
| Finchley |
| London |
| N3 2SZ |
| OSMOSIS (HOLDINGS) LIMITED (REGISTERED NUMBER: 08422391) |
| CONSOLIDATED INCOME STATEMENT |
| FOR THE YEAR ENDED 31 MARCH 2025 |
| 2025 | 2024 |
| Notes | £ | £ |
| TURNOVER | 4 | 6,403,563 | 5,998,101 |
| Administrative expenses | 6,584,932 | 7,994,842 |
| GROUP OPERATING LOSS | 6 | (181,369 | ) | (1,996,741 | ) |
| Share of operating loss in |
| Associates | (231,885 | ) | - |
| Interest receivable and similar income | 289,085 | 35,389 |
| (124,169 | ) | (1,961,352 | ) |
| Interest payable and similar expenses | 7 | - | 226,267 |
| LOSS BEFORE TAXATION | (124,169 | ) | (2,187,619 | ) |
| Tax on loss | 8 | - | - |
| LOSS FOR THE FINANCIAL YEAR | ( |
) | ( |
) |
| Loss attributable to: |
| Owners of the parent | (124,169 | ) | (2,187,619 | ) |
| OSMOSIS (HOLDINGS) LIMITED (REGISTERED NUMBER: 08422391) |
| CONSOLIDATED OTHER COMPREHENSIVE INCOME |
| FOR THE YEAR ENDED 31 MARCH 2025 |
| 2025 | 2024 |
| Notes | £ | £ |
| LOSS FOR THE YEAR | (124,169 | ) | (2,187,619 | ) |
| OTHER COMPREHENSIVE INCOME | - | - |
| TOTAL COMPREHENSIVE INCOME FOR THE YEAR | (124,169 | ) | (2,187,619 | ) |
| Total comprehensive income attributable to: |
| Owners of the parent | (124,169 | ) | (2,187,619 | ) |
| OSMOSIS (HOLDINGS) LIMITED (REGISTERED NUMBER: 08422391) |
| CONSOLIDATED BALANCE SHEET |
| 31 MARCH 2025 |
| 2025 | 2024 |
| Notes | £ | £ | £ | £ |
| FIXED ASSETS |
| Intangible assets | 10 | 1,674,653 | 346,887 |
| Tangible assets | 11 | 6,769 | 1,254 |
| Investments | 12 |
| Interest in associate | (231,800 | ) | - |
| 1,449,622 | 348,141 |
| CURRENT ASSETS |
| Debtors | 13 | 2,910,233 | 2,798,037 |
| Cash at bank | 473,598 | 1,861,536 |
| 3,383,831 | 4,659,573 |
| CREDITORS |
| Amounts falling due within one year | 14 | 1,125,211 | 931,842 |
| NET CURRENT ASSETS | 2,258,620 | 3,727,731 |
| TOTAL ASSETS LESS CURRENT LIABILITIES | 3,708,242 | 4,075,872 |
| CREDITORS |
| Amounts falling due after more than one year | 15 | 1,695,731 | 2,751,626 |
| NET ASSETS | 2,012,511 | 1,324,246 |
| CAPITAL AND RESERVES |
| Called up share capital | 17 | 2,040 | 2,016 |
| Share premium | 18 | 14,326,739 | 13,522,488 |
| Other reserves | 18 | (489 | ) | (489 | ) |
| Retained earnings | 18 | (12,315,779 | ) | (12,199,769 | ) |
| SHAREHOLDERS' FUNDS | 2,012,511 | 1,324,246 |
| The financial statements were approved by the Board of Directors and authorised for issue on 29 October 2025 and were signed on its behalf by: |
| G Stephen - Director |
| OSMOSIS (HOLDINGS) LIMITED (REGISTERED NUMBER: 08422391) |
| COMPANY BALANCE SHEET |
| 31 MARCH 2025 |
| 2025 | 2024 |
| Notes | £ | £ | £ | £ |
| FIXED ASSETS |
| Intangible assets | 10 |
| Tangible assets | 11 |
| Investments | 12 |
| CURRENT ASSETS |
| Debtors | 13 |
| Cash at bank |
| CREDITORS |
| Amounts falling due within one year | 14 |
| NET CURRENT (LIABILITIES)/ASSETS | ( |
) |
| TOTAL ASSETS LESS CURRENT LIABILITIES | ( |
) |
| CREDITORS |
| Amounts falling due after more than one year | 15 |
| NET LIABILITIES | ( |
) | ( |
) |
| CAPITAL AND RESERVES |
| Called up share capital | 17 |
| Share premium | 18 |
| Retained earnings | 18 | ( |
) | ( |
) |
| SHAREHOLDERS' FUNDS | ( |
) | ( |
) |
| Company's loss for the financial year | (2,119,413 | ) | (3,178,512 | ) |
| The financial statements were approved by the Board of Directors and authorised for issue on |
| OSMOSIS (HOLDINGS) LIMITED (REGISTERED NUMBER: 08422391) |
| CONSOLIDATED STATEMENT OF CHANGES IN EQUITY |
| FOR THE YEAR ENDED 31 MARCH 2025 |
| Called up |
| share | Retained | Share | Other | Total |
| capital | earnings | premium | reserves | equity |
| £ | £ | £ | £ | £ |
| Balance at 1 April 2023 | 1,483 | (10,012,150 | ) | 11,092,661 | (489 | ) | 1,081,505 |
| Changes in equity |
| Issue of share capital | 533 | - | 2,429,827 | - | 2,430,360 |
| Total comprehensive income | - | (2,187,619 | ) | - | - | (2,187,619 | ) |
| Balance at 31 March 2024 | 2,016 | (12,199,769 | ) | 13,522,488 | (489 | ) | 1,324,246 |
| Changes in equity |
| Issue of share capital | 24 | - | 804,251 | - | 804,275 |
| Total comprehensive income | - | (116,010 | ) | - | - | (116,010 | ) |
| Balance at 31 March 2025 | 2,040 | (12,315,779 | ) | 14,326,739 | (489 | ) | 2,012,511 |
| OSMOSIS (HOLDINGS) LIMITED (REGISTERED NUMBER: 08422391) |
| COMPANY STATEMENT OF CHANGES IN EQUITY |
| FOR THE YEAR ENDED 31 MARCH 2025 |
| Called up |
| share | Retained | Share | Total |
| capital | earnings | premium | equity |
| £ | £ | £ | £ |
| Balance at 1 April 2023 | ( |
) | ( |
) |
| Changes in equity |
| Issue of share capital | - |
| Total comprehensive income | - | ( |
) | - | ( |
) |
| Balance at 31 March 2024 | ( |
) | ( |
) |
| Changes in equity |
| Issue of share capital | - |
| Total comprehensive income | - | ( |
) | - | ( |
) |
| Balance at 31 March 2025 | ( |
) | ( |
) |
| OSMOSIS (HOLDINGS) LIMITED (REGISTERED NUMBER: 08422391) |
| CONSOLIDATED CASH FLOW STATEMENT |
| FOR THE YEAR ENDED 31 MARCH 2025 |
| 2025 | 2024 |
| Notes | £ | £ |
| Cash flows from operating activities |
| Cash generated from operations | 1 | (9,589 | ) | (2,914,511 | ) |
| Tax paid | 4,175 | (3,310 | ) |
| Net cash from operating activities | (5,414 | ) | (2,917,821 | ) |
| Cash flows from investing activities |
| Purchase of intangible fixed assets | (1,419,493 | ) | (60,600 | ) |
| Purchase of tangible fixed assets | (8,214 | ) | (1,016 | ) |
| Purchase of fixed asset investments | (85 | ) | - |
| Sale of short-term listed investments | - | 77,503 |
| Purchase of short-term unlstd investment | - | (72,728 | ) |
| Interest received | 289,085 | 35,389 |
| Net cash from investing activities | (1,138,707 | ) | (21,452 | ) |
| Cash flows from financing activities |
| Loan repayments in year | (1,055,895 | ) | - |
| Amount withdrawn by directors | (356 | ) | - |
| Share issue | 24 | 533 |
| Share premium | 804,251 | 2,429,594 |
| Capital distribution | - | (256 | ) |
| Net cash from financing activities | (251,976 | ) | 2,429,871 |
| Decrease in cash and cash equivalents | (1,396,097 | ) | (509,402 | ) |
| Cash and cash equivalents at beginning of year | 2 | 1,861,536 | 2,370,938 |
| Effect of foreign exchange rate changes | 8,159 | - |
| Cash and cash equivalents at end of year | 2 | 473,598 | 1,861,536 |
| OSMOSIS (HOLDINGS) LIMITED (REGISTERED NUMBER: 08422391) |
| NOTES TO THE CONSOLIDATED CASH FLOW STATEMENT |
| FOR THE YEAR ENDED 31 MARCH 2025 |
| 1. | RECONCILIATION OF LOSS BEFORE TAXATION TO CASH GENERATED FROM OPERATIONS |
| 2025 | 2024 |
| £ | £ |
| Loss before taxation | (124,169 | ) | (2,187,619 | ) |
| Depreciation charges | 94,426 | 120,552 |
| Associated company loss | 231,885 | - |
| Finance costs | - | 226,267 |
| Finance income | (289,085 | ) | (35,389 | ) |
| (86,943 | ) | (1,876,189 | ) |
| Increase in trade and other debtors | (111,840 | ) | (1,390,132 | ) |
| Increase in trade and other creditors | 189,194 | 351,810 |
| Cash generated from operations | (9,589 | ) | (2,914,511 | ) |
| 2. | CASH AND CASH EQUIVALENTS |
| The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts: |
| Year ended 31 March 2025 |
| 31.3.25 | 1.4.24 |
| £ | £ |
| Cash and cash equivalents | 473,598 | 1,861,536 |
| Year ended 31 March 2024 |
| 31.3.24 | 1.4.23 |
| £ | £ |
| Cash and cash equivalents | 1,861,536 | 2,370,938 |
| 3. | ANALYSIS OF CHANGES IN NET DEBT |
| At 1.4.24 | Cash flow | At 31.3.25 |
| £ | £ | £ |
| Net cash |
| Cash at bank and in hand | 1,861,536 | (1,387,938 | ) | 473,598 |
| 1,861,536 | (1,387,938 | ) | 473,598 |
| Debt |
| Debts falling due after 1 year | (2,751,626 | ) | 1,055,895 | (1,695,731 | ) |
| (2,751,626 | ) | 1,055,895 | (1,695,731 | ) |
| Total | (890,090 | ) | (332,043 | ) | (1,222,133 | ) |
| OSMOSIS (HOLDINGS) LIMITED (REGISTERED NUMBER: 08422391) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS |
| FOR THE YEAR ENDED 31 MARCH 2025 |
| 1. | STATUTORY INFORMATION |
| Osmosis (Holdings) Limited is a |
| 2. | ACCOUNTING POLICIES |
| Basis of preparing the financial statements |
| The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006. |
| The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires Group management to exercise Judgement in applying the Group's accounting policies (see note 3). |
| The Company has taken advantage of the exemption allowed under section 408 of the Companies Act 2006 and has not presented its own Statement of comprehensive income in these financial statements. |
| The following principal accounting policies have been applied: |
| Basis of consolidation: |
| The consolidated financial statements present the results of Group and its own subsidiaries ("the Group") as if they formed a single entity. Intercompany transactions and balances between group companies are therefore eliminated In full. |
| The consolidated financial statements incorporate the results of business combinations using the purchase method. In the Statement of financial position, the acquiree's Identifiable assets, liabilities and contingent liabilities are initially recognised at their fair values at the acquisition date. The results of acquired operations are included in the Consolidated statement of income and retained earnings from the date on which control is obtained. They are deconsolidated from the date control ceases. |
| During 2020 the company established an Employee Benefit Trust over which control is exercised, this is therefore also included within the consolidated results of the group. |
| The company has taken advantage of the exemption contained within 408 of the Companies Act 2006 not to present its own Statement of comprehensive income. |
| Associates |
| When accounting for associates the group uses equity accounting. This is done by adjusting the initial investment value by any share of the company's post acquisition profit and loss. |
| Turnover |
| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. |
| Tangible fixed assets |
| Investments in subsidiaries and associates |
| The company accounts for investments in subsidiary and associate undertakings at cost. |
| OSMOSIS (HOLDINGS) LIMITED (REGISTERED NUMBER: 08422391) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 MARCH 2025 |
| 2. | ACCOUNTING POLICIES - continued |
| Financial instruments |
| The Group only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable, loans from banks and other third parties, loans to related parties and investments in non-puttable ordinary shares. |
| Basic financial assets and liabilities that are payable or receivable within one year, typically trade payables or receivables, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration, expected to be paid or received. |
| Taxation |
| Taxation for the year comprises current and deferred tax. Tax is recognised in the Consolidated Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
| Current or deferred taxation assets and liabilities are not discounted. |
| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. |
| Deferred tax |
| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. |
| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. |
| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
| Foreign currencies |
| Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions. |
| At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined. |
| Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges. |
| Hire purchase and leasing commitments |
| Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease. |
| Pension costs and other post-retirement benefits |
| The group operates a defined contribution pension scheme. Contributions payable to the group's pension scheme are charged to profit or loss in the period to which they relate. |
| OSMOSIS (HOLDINGS) LIMITED (REGISTERED NUMBER: 08422391) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 MARCH 2025 |
| 3. | CRITICAL ACCOUNTING JUDGEMENTS AND KEY SOURCES OF ESTIMATION UNCERTAINTY |
| Useful economic lives of intangible fixed assets |
| The annual amortisation charge for the development costs is sensitive to changes in the estimated useful economic life. The useful economic life is re-assessed annually in correlation to the performance of the the group investment strategies. See Note 12 for the carrying amount of the development costs and Note 2.5 for the useful life. |
| Share based payment |
| Shares and the beneficial lights attached to shares are issued to certain employees and Directors. The detail of these arrangements are shown in Note 18 and Note 20. |
| The Directors have assessed the fair value of the shares and the beneficial rights at the point they were awarded. Due to the losses incurred by the group and the prospects at that date, they believe the fair value to be in line with the face value of the shares. If this were not the case and the fair value was in excess of this, then a share based payment charge would be required to be recognised within the financial statements. |
| Convertible loan |
| During the year the company received a loan from a third party which includes an option to convert to share capital under certain scenarios. Management have therefore assessed the loan and considered whether there is any element of the loan which is equity in nature. It is considered that the loan was issued at a market rate with no significant benefit being obtained from the inclusion of the conversion and therefore it is considered that there is no equity element to recognise. |
| 4. | TURNOVER |
| The turnover and loss before taxation are attributable to the principal activities of the group. |
| An analysis of turnover by geographical market is given below: |
| 2025 | 2024 |
| £ | £ |
| United Kingdom | 864,284 | 145,129 |
| Europe | 3,653,672 | 4,427,678 |
| United States of America | 526,372 | - |
| Rest of The World | 1,359,235 | 1,425,294 |
| 6,403,563 | 5,998,101 |
| Revenue represents fee income earned in respect of funds under management. Revenue is recognised to the extent that it is probable that the economic benefits will flow to the entity and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. |
| 5. | EMPLOYEES AND DIRECTORS |
| 2025 | 2024 |
| £ | £ |
| Wages and salaries | 2,960,346 | 812,490 |
| Social security costs | 409,580 | 336,480 |
| Other pension costs | 83,566 | 74,189 |
| 3,453,492 | 1,223,159 |
| OSMOSIS (HOLDINGS) LIMITED (REGISTERED NUMBER: 08422391) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 MARCH 2025 |
| 5. | EMPLOYEES AND DIRECTORS - continued |
| The average number of employees during the year was as follows: |
| 2025 | 2024 |
| Directors | 6 | 6 |
| Distribution | 4 | 3 |
| Investment Management | 20 | 15 |
| Central Operations | 6 | 6 |
| The average number of employees by undertakings that were proportionately consolidated during the year was 36 (2024 - 30 ) . |
| 2025 | 2024 |
| £ | £ |
| Directors' remuneration | 535,776 | 556,821 |
| Directors' pension contributions to money purchase schemes | 15,150 | 14,437 |
| The number of directors to whom retirement benefits were accruing was as follows: |
| Defined benefit schemes | 2 | 2 |
| Information regarding the highest paid director is as follows: |
| 2025 | 2024 |
| £ | £ |
| Emoluments etc | 320,888 | 342,013 |
| Pension contributions to money purchase schemes | 9,090 | 8,625 |
| 6. | OPERATING LOSS |
| The operating loss is stated after charging: |
| 2025 | 2024 |
| £ | £ |
| Hire of plant and machinery | 3,886 | - |
| Depreciation - owned assets | 2,699 | 37,966 |
| Computer software amortisation | 91,727 | 82,586 |
| Auditors' remuneration | 42,500 | 14,000 |
| Foreign exchange differences | 89,459 | 50,435 |
| 7. | INTEREST PAYABLE AND SIMILAR EXPENSES |
| 2025 | 2024 |
| £ | £ |
| Convertible loan interest | - | 226,267 |
| 8. | TAXATION |
| Analysis of the tax charge |
| No liability to UK corporation tax arose for the year ended 31 March 2025 nor for the year ended 31 March 2024. |
| 9. | INDIVIDUAL INCOME STATEMENT |
| As permitted by Section 408 of the Companies Act 2006, the Income Statement of the parent company is not presented as part of these financial statements. |
| OSMOSIS (HOLDINGS) LIMITED (REGISTERED NUMBER: 08422391) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 MARCH 2025 |
| 10. | INTANGIBLE FIXED ASSETS |
| Group |
| Computer |
| software |
| £ |
| COST |
| At 1 April 2024 | 864,613 |
| Additions | 1,419,493 |
| At 31 March 2025 | 2,284,106 |
| AMORTISATION |
| At 1 April 2024 | 517,726 |
| Amortisation for year | 91,727 |
| At 31 March 2025 | 609,453 |
| NET BOOK VALUE |
| At 31 March 2025 | 1,674,653 |
| At 31 March 2024 | 346,887 |
| 11. | TANGIBLE FIXED ASSETS |
| Group |
| Fixtures |
| and | Computer |
| fittings | equipment | Totals |
| £ | £ | £ |
| COST |
| At 1 April 2024 | 131,833 | 98,516 | 230,349 |
| Additions | - | 8,214 | 8,214 |
| At 31 March 2025 | 131,833 | 106,730 | 238,563 |
| DEPRECIATION |
| At 1 April 2024 | 131,833 | 97,262 | 229,095 |
| Charge for year | - | 2,699 | 2,699 |
| At 31 March 2025 | 131,833 | 99,961 | 231,794 |
| NET BOOK VALUE |
| At 31 March 2025 | - | 6,769 | 6,769 |
| At 31 March 2024 | - | 1,254 | 1,254 |
| OSMOSIS (HOLDINGS) LIMITED (REGISTERED NUMBER: 08422391) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 MARCH 2025 |
| 11. | TANGIBLE FIXED ASSETS - continued |
| Company |
| Fixtures |
| and | Computer |
| fittings | equipment | Totals |
| £ | £ | £ |
| COST |
| At 1 April 2024 |
| Additions |
| At 31 March 2025 |
| DEPRECIATION |
| At 1 April 2024 |
| Charge for year |
| At 31 March 2025 |
| NET BOOK VALUE |
| At 31 March 2025 |
| At 31 March 2024 |
| 12. | FIXED ASSET INVESTMENTS |
| Group |
| Interest |
| in |
| associate |
| £ |
| COST |
| Additions | 85 |
| Share of profit/(loss) | (231,885 | ) |
| At 31 March 2025 | (231,800 | ) |
| NET BOOK VALUE |
| At 31 March 2025 | (231,800 | ) |
| Interest in associate |
| Osmosis Investments Management Netherlands | 2025 |
| £ |
| Loss for the year | (231,885 | ) |
| Share of net liabilities | (231,885 | ) |
| OSMOSIS (HOLDINGS) LIMITED (REGISTERED NUMBER: 08422391) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 MARCH 2025 |
| 12. | FIXED ASSET INVESTMENTS - continued |
| Company |
| Shares in |
| group |
| undertakings |
| £ |
| COST |
| At 1 April 2024 |
| Additions |
| At 31 March 2025 |
| NET BOOK VALUE |
| At 31 March 2025 |
| At 31 March 2024 |
| The following were subsidiary undertakings of the Company: |
| Name | Class of Shares | Holding |
| Osmosis Investment Management UK Limited | Ordinary | 100% |
| Osmosis Investment Research Solutions Limited | Ordinary | 100% |
| Osmosis Investment Management US LLC | Ordinary | 100% |
| Osmosis US LLC | Ordinary | 100% |
| Osmosis GP LLC | Ordinary | 100% |
| Osmosis Investments Limited | Ordinary | 100% |
| Osmosis Capital Limited | Ordinary | 100% |
| Osmosis Investment Management Australia Pty Limited | Ordinary | 100% |
| Osmosis Investment Management Netherlands | Ordinary | 33.916% |
| All of the above were incorporated in the United Kingdom with the exception of Osmosis Investment Management US LLC, Osmosis US LLC and Osmosis GP LLC which are incorporated in the USA and Osmosis Investment Management Australia Pty Limited, which is incorporated in Australia. |
| The registered office of the above is 36-38 Botolph Lane, London, EC3R BDE. |
| During the year, the Group acquired a 33.916% share of Osmosis Investment Management Netherlands Limited, with share capital of £84. |
| 13. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| Group | Company |
| 2025 | 2024 | 2025 | 2024 |
| £ | £ | £ | £ |
| Trade debtors | 736,525 | 424,766 |
| Amounts owed by group undertakings | - | - |
| Other debtors | 139,747 | 616,514 |
| Directors' current accounts | 356 | - | 356 | - |
| VAT | 28,025 | 9,624 |
| Prepayments and accrued income | 2,005,580 | 1,747,133 |
| 2,910,233 | 2,798,037 |
| OSMOSIS (HOLDINGS) LIMITED (REGISTERED NUMBER: 08422391) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 MARCH 2025 |
| 14. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| Group | Company |
| 2025 | 2024 | 2025 | 2024 |
| £ | £ | £ | £ |
| Trade creditors | 699,625 | 577,317 |
| Amounts owed to group undertakings | 15,837 | - |
| Tax | 4,175 | - |
| Social security and other taxes | 106,461 | - |
| VAT | - | - | 130,646 | - |
| Other creditors | 33,048 | 48,231 |
| Accruals and deferred income | 266,065 | 306,294 |
| 1,125,211 | 931,842 |
| 15. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR |
| Group | Company |
| 2025 | 2024 | 2025 | 2024 |
| £ | £ | £ | £ |
| Other loans (see note 16) | 1,695,731 | 2,751,626 |
| 16. | LOANS |
| An analysis of the maturity of loans is given below: |
| Group | Company |
| 2025 | 2024 | 2025 | 2024 |
| £ | £ | £ | £ |
| Amounts falling due between two and five years: |
| Other loans - 2-5 years | 1,695,731 | 2,751,626 |
| 17. | CALLED UP SHARE CAPITAL |
| 2025 | 2024 |
| £ | £ |
| Alloted, called up and fully paid |
| 12,850,019 (2023: 12,708,281) - A Ordinary Shares of £0.0001 | 1,285 | 1,271 |
| 4,891,049 - E Ordinary Shares of £0.0001 | 489 | 489 |
| 595,925 - Deferred shares of £0.0001 | 60 | 60 |
| 2,061,231 (2023: 1,964,865) - Non voting A Ordinary shares of £0.0001 | 206 | 196 |
| 2,040 | 2,016 |
| During the year the following shares were allotted: |
| 141,738 A Ordinary shares of £0.0001 each for cash proceeds totalling £478,767, generating a share premium of £478,753. |
| 96,366 Non voting A Ordinary shares of £0.0001 each for cash proceeds totalling £325,508, generating a share premium of £325,498.. |
| OSMOSIS (HOLDINGS) LIMITED (REGISTERED NUMBER: 08422391) |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 MARCH 2025 |
| 18. | RESERVES |
| Group |
| Retained | Share | Other |
| earnings | premium | reserves | Totals |
| £ | £ | £ | £ |
| At 1 April 2024 | (12,199,769 | ) | 13,522,488 | (489 | ) | 1,322,230 |
| Deficit for the year | (124,169 | ) | (124,169 | ) |
| Purchase in year | 8,159 | 804,251 | - | 812,410 |
| At 31 March 2025 | (12,315,779 | ) | 14,326,739 | (489 | ) | 2,010,471 |
| Company |
| Retained | Share |
| earnings | premium | Totals |
| £ | £ | £ |
| At 1 April 2024 | ( |
) | (788,771 | ) |
| Deficit for the year | ( |
) | ( |
) |
| Purchase in year | - | 804,251 | 804,251 |
| At 31 March 2025 | ( |
) | (2,103,933 | ) |